ADMS - Adamas to Present at Upcoming Evercore ISI Conference

EMERYVILLE, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, the Company’s Chief Executive Officer, is scheduled to present at the Evercore ISI 3 ^rd Annual HealthCONx Conference on Tuesday, December 1 ^st at 11:45 am Eastern Time (8:45 am Pacific).

The presentation will be webcast from the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations . Archived versions of the webcast will be available via replay for 30 days following the presentation.

About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com .

Contact

Media:
Sarah Mathieson
Vice President, Corporate Communications
510-450-3528
smathieson@adamaspharma.com

Investors:
Peter Vozzo
Managing Director, Westwicke
443-213-0505
peter.vozzo@westwicke.com